Orencia clickject 125 MG/mlml
Ended Awarded Last action
- Contract number
- SPE2DR26FV7G7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,459
Award facts
- Contract value 100% obligated
- $22,458.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $22,458.77 for Orencia ClickJect 125 mg/mL by the Defense Logistics Agency (DLA). The contract, issued on January 2, 2026, is a firm fixed price delivery order with an ultimate completion date of January 5, 2026, and was competitively awarded with no set-aside designation. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026 that serves as the comprehensive global pharmaceutical support vehicle for military healthcare systems worldwide.
Orencia ClickJect is a biologic immunosuppressant medication used in the treatment of rheumatoid arthritis and other autoimmune conditions, reflecting AmerisourceBergen's role as a critical supplier of specialty pharmaceuticals to federal healthcare programs. The delivery order demonstrates the company's ongoing capability to supply brand-name specialty medications and biologics to support Defense Health Agency requirements and broader military medical supply needs. AmerisourceBergen's extensive portfolio of federal pharmaceutical contracts with DLA, ranging from small-value transactions to substantial orders, underscores its significance as a trusted vendor for federal medical procurement across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FV7G7?
SPE2DR26FV7G7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 2, 2026.
How much is contract SPE2DR26FV7G7 worth?
The government has obligated $22,459 on SPE2DR26FV7G7.
Is contract SPE2DR26FV7G7 an order under another contract?
Yes. SPE2DR26FV7G7 is a delivery order under SPE2DR25D2214, an indefinite delivery contract.
Was contract SPE2DR26FV7G7 competed?
The extent of competition for SPE2DR26FV7G7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award